Drugs / Uniflu
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03789539 Comparator | Jun → Dec 2018 | — | VA Pharma Limited Liability Company | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Uniflu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03789539 ↗ |
| Known as | Universal Influenza Vaccine Uniflu | “low dose Universal Influenza Vaccine Uniflu” NCT03789539 ↗ |
| Modality | Vaccine | “Uniflu vaccine” NCT03789539 ↗ |